Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - zolmitriptan, quantity: 2.5 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; lactose; sodium starch glycollate type a; titanium dioxide; hypromellose; macrogol 6000; iron oxide red; macrogol 400 - for the acute treatment of migraine with or without aura.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - zolmitriptan -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duopharma marketing sdn. bhd. - diclofenac sodium -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duopharma marketing sdn. bhd. - diclofenac sodium -

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: bliss pharma distribution and consultancy corp.; distributor: dreamax incorporated - zoledronic acid - lyophilized powder for iv infusion - 4 mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

life biopharma sdn. bhd. - sulfamethoxazole; trimethoprim -

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - sertraline hydrochloride, quantity: 111.9 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: hyprolose; calcium hydrogen phosphate; sodium starch glycollate type a; magnesium stearate; polysorbate 80; microcrystalline cellulose; hypromellose; titanium dioxide; macrogol 400 - treatment of children aged 6 years and older and adolescents with obsessive compulsive disorder. ,treatment of major depression, obsessive compulsive disorder and panic disorder in adults. treatment of social phobia (social anxiety disorder) and the prevention of its relapse in adults.,treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - sertraline hydrochloride, quantity: 55.95 mg (equivalent: sertraline, qty 50 mg) - tablet, film coated - excipient ingredients: polysorbate 80; magnesium stearate; titanium dioxide; hyprolose; microcrystalline cellulose; sodium starch glycollate type a; calcium hydrogen phosphate; hypromellose; macrogol 400 - treatment of children aged 6 years and older and adolescents with obsessive compulsive disorder. ,treatment of major depression, obsessive compulsive disorder and panic disorder in adults. treatment of social phobia (social anxiety disorder) and the prevention of its relapse in adults.,treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

life biopharma sdn. bhd. - sulfamethoxazole; trimethoprim -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - zolmitriptan, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose; magnesium stearate; microcrystalline cellulose; sodium starch glycollate type a; titanium dioxide; hypromellose; macrogol 6000; iron oxide red; macrogol 400 - acute relief of migraine in patients who have a stable, well-established pattern of symptoms.